| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 9.760.868.193 $ | +1.652.764.827 $ | +19,8 % | 8.115.527.458 $ | +2.161.121.455 $ | +30,2 % | 5.935.681.007 $ | +48.363.720 $ | +1,3 % | ||
| BANK OF AMERICA CORP /DE/ | BAC | 7.150.116.907 $ | +1.362.036.030 $ | +23,5 % | 5.788.080.877 $ | +1.834.622.572 $ | +46,4 % | 3.953.458.305 $ | -129.447.645 $ | -3,2 % |
| Ascendis Pharma A/S | ASND | 2.192.426.207 $ | +148.361.987 $ | +7,3 % | 2.044.064.220 $ | +269.478.010 $ | +15,2 % | 1.774.586.210 $ | +172.112.243 $ | +10,7 % |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 123.452.051 $ | +123.452.051 $ | |||||||
| GH Research PLC | GHRS | 97.494.052 $ | -12.282.715 $ | -11,2 % | 109.776.767 $ | +16.197.831 $ | +17,3 % | 93.578.936 $ | +16.979.469 $ | +22,2 % |
| GERON CORP | GERN | 84.178.203 $ | +1.458.472 $ | +1,8 % | 82.719.731 $ | -2.415.175 $ | -2,8 % | 85.134.906 $ | -10.868.286 $ | -11,3 % |
| LB PHARMACEUTICALS INC | LBRX | 49.163.525 $ | +21.105.358 $ | +75,2 % | 28.058.167 $ | +28.058.167 $ | ||||
| Monopar Therapeutics | MNPR | 43.568.617 $ | +1.818.341 $ | +4,4 % | 41.750.276 $ | +23.459.290 $ | +128,3 % | 18.290.986 $ | -322.061 $ | -1,7 % |
| MORGAN STANLEY | MS | 9.772.500 $ | +1.822.500 $ | +22,9 % | 7.950.000 $ | -15.000 $ | -0,2 % | 7.965.000 $ | +240.000 $ | +3,1 % |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 7.666.659 $ | +1.963.331 $ | +34,4 % | 5.703.328 $ | +3.036.664 $ | +113,9 % | 2.666.664 $ | -330.000 $ | -11,0 % | |
| GLAUKOS Corp | GKOS | 4.418.379 $ | -14.306.617 $ | -76,4 % | ||||||
| EXACT SCIENCES CORP | EXAS | 3.005.713 $ | +3.005.713 $ | |||||||
| ORTHOPEDIATRICS CORP | KIDS | 1.952.872 $ | +1.952.872 $ | |||||||
| PALATIN TECHNOLOGIES INC | PTNT | 1.076.600 $ | +1.076.600 $ | |||||||
| 9.760.868.193 $ | +1.652.764.827 $ | +19,8 % | 8.115.527.458 $ | +2.161.121.455 $ | +30,2 % | 5.935.681.007 $ | +48.363.720 $ | +1,3 % | ||